We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




microRNA-Based Molecular Diagnostics Company Developing New Cancer Tests

By LabMedica International staff writers
Posted on 22 Dec 2009
A microRNA-based molecular diagnostics company has disclosed that it intends to develop and commercialize three new tests for cancer during the next two years.

Rosetta Genomics (Rehovot, Israel) is working to develop the second-generation miRview mets, a test for cancer of unknown primary. More...
The current version of this test has a tumor panel of 25 cancers. The company is designing a test to identify a much larger panel of cancer origins, which it expects to market by the second half of 2010.

After differentiating small-cell lung cancer from non-small-cell lung cancer, a test will further subclassify non-small-cell lung cancer into squamous or nonsquamous. This test is being developed to leverage the company's new Fine Needle Aspirate (FNA) platform technology across several types of tests. The company aims to launch the extended lung cancer diagnostic in the second half of 2011.

The third test being developed by Rosetta Genomics is for bladder cancer. The aim of this test is to predict the risk of superficial bladder cancer becoming invasive. The target date for commercialization is late 2011.

Rosetta Genomics is a developer of microRNA-based molecular diagnostics. Its integrative research platform, combining bioinformatics and state-of-the-art laboratory processes, has led to the discovery of hundreds of biologically validated novel human microRNAs. The company is working on the application of these technologies in the development of a full range of microRNA-based diagnostic tools.

Related Links:

Rosetta Genomics




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.